Volunteers are the heart of Rally's mission!
2019 Rally Foundation Year In Review
Thank you for caring about kids fighting cancer, and thank you for giving toRally For Their Future. Rally Kid Brecklynn, who is six years...
Success Stories
read more
How Rally Kid Ruby is Making an Impact on Childhood Cancer Research
You might remember Rally Kid Ruby from Year End Giving three years ago. She was diagnosed with embryonal rhabdomyosarcoma, a form of soft...
Research for Recurrent Brain Tumors Shows Promising Preliminary Results
As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to...
New Developments in Osteosarcoma Therapies
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
Success Stories
AML Treatment Developments
Rally Foundation for Childhood Cancer Research is excited to announce new developments in the treatment of childhood acute myeloid leukemia (AML) emerging from research in the Meshinchi laboratory at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle. Immunotherapy is a type of treatment that harnesses the immune system to kill cancer cells. To avoid toxicity and unpleasant side effects of treatment, researchers search for molecules or a “target” on the surface of cancer cells...
The New England Journal of Medicine
Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New England Journal of Medicine logo, an article about Dr. Friedman’s brain cancer research and an acknowledgement to Rally for our support. “As a young investigator in 2013, I received my first grant directly supporting my lab research from Rally. The support enabled us to obtain the critical preclinical data needed for FDA approval to conduct the first pediatric...
How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2
Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are...
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’
Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational...
2019 Rally Foundation Year In Review
Thank you for caring about kids fighting cancer, and thank you for giving toRally For Their Future. Rally Kid Brecklynn, who is six years old and has fought cancer twice, put it best: She said that all she wanted was to be a “plain girl,” meaning she just wanted to be a normal little girl playing dress up and having tea parties—not getting needle pokes and chemo cocktails. Your financial gift allows kids like Brecklynn, who are fighting cancer, to have the chance to be a “plain kid.” Your gift...
How Rally Kid Ruby is Making an Impact on Childhood Cancer Research
You might remember Rally Kid Ruby from Year End Giving three years ago. She was diagnosed with embryonal rhabdomyosarcoma, a form of soft tissue cancer, on April 17, 2015. As part of her cancer treatment, she underwent a brutal combination of chemotherapy and proton radiation. Despite the ups and downs of her battle with cancer, Ruby is now thriving. As a 15-year-old sophomore, she is working to make an impact on childhood cancer research. Watch the videos below to see the difference she is...